Targeting Mdmx to treat breast cancers with wild-type p53
Sue Haupt(UNSW Sydney), Ygal Haupt(The University of Melbourne)
Cited by 43
Related Papers
E6AP promotes the degradation of the PML tumor suppressor
|Cell Death and Differentiation|2009|93
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
|Frontiers in Oncology|2016|56